Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Seungwoo ChangDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.
Luisa LauretiCancer Research Center of Marseille: Team DNA Damage and Genome Instability|CNRS, Aix Marseille Université, Inserm, Institut Paoli-Calmettes, Marseille F-13009, France.
Elizabeth S ThrallDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.ORCID 0000-0002-7670-3939
Marguerite S KayDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.
Gaëlle PhilippinCancer Research Center of Marseille: Team DNA Damage and Genome Instability|CNRS, Aix Marseille Université, Inserm, Institut Paoli-Calmettes, Marseille F-13009, France.
Slobodan JergicSchool of Chemistry and Molecular Bioscience, Molecular Horizons, University of Wollongong, Wollongong, NSW 2522, Australia.
Vincent PagèsCancer Research Center of Marseille: Team DNA Damage and Genome Instability|CNRS, Aix Marseille Université, Inserm, Institut Paoli-Calmettes, Marseille F-13009, France.ORCID 0000-0002-3059-2903
Joseph J LoparoDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.ORCID 0000-0003-4941-4696
Funding
Regulation of translesion synthesis by the bacterial replisomeR01GM114065 · NIGMS · HARVARD MEDICAL SCHOOL · PI LOPARO, JOSEPH J. · 2015 to 2024
$3.0M
Visualizing the Bacterial Replisome at Single-Molecule ResolutionF32GM113516 · NIGMS · HARVARD MEDICAL SCHOOL · PI THRALL, ELIZABETH SIMMONS · 2015 to 2016
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A bipartite interaction with the processivity clamp potentiates Pol IV-mediated TLS. · full record | OpenQuestion